Fischer Medical Ventures Ltd.

38.14-2.08%

2026-08-21

fischermv.comBSE: 524743NSE: FISCHER
Market Cap₹ 2,716 Cr.
Current Price₹ 39
High / Low₹ 125 / 31
Stock P/E91.1
Book Value₹ 7
Price to Book18.64
Dividend Yield0.00 %
ROCE1.1 %
ROE0.6 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Working capital cycle has improved - days down from 1158 to 869
  • Company maintains a comfortable, low leverage position

CONS

  • Operating cash flow has been negative in recent years
  • A large part of profit comes from other income (67.1% of PBT)
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -31.27x)
  • Promoter holding has decreased over last 2 years: -12.8pp
  • Company has a low return on equity of 1.7% over last 3 years
  • Company has a low return on capital employed of 3.8%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.ADANIENT2979.0054.17403273.960.04-1461.54-249.6732923.9849.9213.3015.57
2.AEGISLOG1363.6538.2547864.120.64544.84210.702356.8637.0719.7630.28
3.PREMIERENE1008.0027.4845758.310.104719.181433.2324625.941252.5241.9729.03
4.CPPLUS3307.4581.9839127.280.05142.20332.511402.4289.5129.4814.52
5.REDINGTON334.9015.3926181.631.79453.4994.6534922.4734.5718.962.03
6.HONASA476.9062.4815548.090.6390.45118.87755.9527.008.9914.58
7.LLOYDSENT78.59106.8411997.170.19109.98-55.77563.0370.1512.8418.07
8.SGMART805.8081.6910155.920.00455.801310.7113085.701044.0811.454.49
9.MMTC62.1020.829315.000.00104.24135.520.68-50.006.90-1423.53
10.CELLO358.4525.317917.620.4273.40-8.99526.72-0.4317.1518.80
11.EBGNG588.8047.136713.000.0028.9356.21412.4632.0820.1411.97
12.FISCHER38.8891.082716.490.003.79-24.3081.92249.341.1313.73
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
21
18
Operating Profit
OPM %
Other Income
0
Interest
0
Depreciation
0
3
Tax %
6.18%
Net Profit
0
1
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
10
10
Operating Profit
OPM %
Other Income
1
Interest
0
Depreciation
0
0
Tax %
237.50%
Net Profit
-0
-0
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
40
39
Operating Profit
OPM %
Other Income
0
Interest
0
Depreciation
0
0
Tax %
-21.05%
Net Profit
0
0
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
12
11
Operating Profit
OPM %
Other Income
0
Interest
0
Depreciation
1
0
Tax %
168.00%
Net Profit
-3
-0
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
54
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
49
47
Operating Profit
OPM %
Other Income
0
Interest
0
Depreciation
1
2
Tax %
26.04%
Net Profit
1
0
Equity Capital
64
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
64
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
23
19
Operating Profit
OPM %
Other Income
7
Interest
1
Depreciation
1
10
Tax %
50.84%
Net Profit
5
0
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
86
70
Operating Profit
OPM %
Other Income
2
Interest
1
Depreciation
1
17
Tax %
19.48%
Net Profit
14
2
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
101
80
Operating Profit
OPM %
Other Income
1
Interest
1
Depreciation
1
21
Tax %
9.18%
Net Profit
19
0
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
98
97
Operating Profit
OPM %
Other Income
1
Interest
4
Depreciation
1
-2
Tax %
-216.00%
Net Profit
-7
-0
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
82
76
Operating Profit
OPM %
Other Income
1
Interest
4
Depreciation
1
8
Tax %
51.60%
Net Profit
4
0
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
65
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
0
0
Operating Profit
0
OPM %
8
Other Income
0
Interest
0
Depreciation
0
-0
Tax %
-2,708
Net Profit
-0
EPS
-2
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-0
Mar 2024
21
19
Operating Profit
2
OPM %
11
Other Income
1
Interest
0
Depreciation
0
2
Tax %
13
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
-0
Share of Associates
0
Adjusted EPS
0
Minority Interest
-0
Share of Associates
0
Adjusted EPS
0
Mar 2025
111
107
Operating Profit
5
OPM %
4
Other Income
1
Interest
0
Depreciation
2
2
Tax %
46
Net Profit
1
EPS
0
Dividend Payout %
22
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
TTM
367
322
Operating Profit
OPM %
Other Income
6
Interest
9
Depreciation
4
44
Tax %
32
Net Profit
30
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
-0
Adjusted EPS
Minority Interest
0
Share of Associates
-0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
5 Years:
3 Years:

COMPOUNDED PROFIT GROWTH

10 Years:
5 Years:
3 Years:

STOCK PRICE CAGR

10 Years:
5 Years:
3 Years:
1 Year:
-62%

RETURN ON EQUITY

10 Years:
5 Years:
3 Years:
2%
Last Year:
1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2025

Sep 22

Rs.0.0500 per share(0.50%) Final Dividend

Mar 2023
Equity Capital
0
-0
0
Trade Payables
0
0
Total Liabilities
0
0
Capital Work in Progress
0
0
0
0
Cash & Bank
0
0
Total Assets
0
Total Debt
1
Net Working Capital
0
Contingent Liabilities
0
Book Value per Share
-15.47
Face Value
10.00
Total Debt
1
Net Working Capital
0
Contingent Liabilities
0
Book Value per Share
-15.47
Face Value
10.00
Mar 2024
Equity Capital
54
27
0
Trade Payables
2
4
Total Liabilities
86
15
Capital Work in Progress
0
1
4
23
Cash & Bank
38
5
Total Assets
86
Total Debt
0
Net Working Capital
67
Contingent Liabilities
0
Book Value per Share
15.00
Face Value
10.00
Total Debt
0
Net Working Capital
67
Contingent Liabilities
0
Book Value per Share
15.00
Face Value
10.00
Mar 2025
Equity Capital
64
244
60
Trade Payables
21
69
Total Liabilities
457
24
Capital Work in Progress
1
11
9
76
Cash & Bank
251
85
Total Assets
457
Total Debt
60
Net Working Capital
263
Contingent Liabilities
0
Book Value per Share
48.17
Face Value
10.00
Total Debt
60
Net Working Capital
263
Contingent Liabilities
0
Book Value per Share
48.17
Face Value
10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
0
Cash from Investing
0
Cash from Financing
0
0
Free Cash Flow
0
OCF / Net Profit
-0.00
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.00
Cumulative 5-Year FCF
0
Mar 2024
-7
Cash from Investing
-31
Cash from Financing
37
-2
Free Cash Flow
-23
OCF / Net Profit
-4.00
Cumulative 5-Year FCF
0
OCF / Net Profit
-4.00
Cumulative 5-Year FCF
0
Mar 2025
-87
Cash from Investing
-125
Cash from Financing
315
103
Free Cash Flow
-99
OCF / Net Profit
-71.81
Cumulative 5-Year FCF
0
OCF / Net Profit
-71.81
Cumulative 5-Year FCF
0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023
EPS (₹)
-2.12
Book Value (₹)
-15.47
Dividend per Share (₹)
0.00
Cash EPS (₹)
-0.21
Operating Margin %
8.47%
Net Margin %
-20.33%
ROE %
0.00%
ROCE %
4.97%
-14.72%
Debtor Days
347
Inventory Days
0
Payable Days
0
347
Debt to Equity (x)
-2.15x
Interest Coverage (x)
0.92x
5.18x
Revenue Growth %
0.00%
Operating Profit Growth %
0.00%
Net Profit Growth %
0.00%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
0.26
Book Value (₹)
15.00
Dividend per Share (₹)
0.00
Cash EPS (₹)
0.04
Operating Margin %
8.86%
Net Margin %
8.76%
ROE %
4.60%
ROCE %
5.35%
4.25%
Debtor Days
200
Inventory Days
78
Payable Days
24
254
Debt to Equity (x)
0.00x
Interest Coverage (x)
32.23x
18.37x
Revenue Growth %
0.00%
Operating Profit Growth %
0.00%
Net Profit Growth %
5135.34%
112.14%
P/E (x)
242.49x
P/B (x)
41.65x
Dividend Yield %
0.00%
1399.44x
Mar 2025
EPS (₹)
0.23
Book Value (₹)
48.17
Dividend per Share (₹)
0.05
Cash EPS (₹)
0.04
Operating Margin %
3.02%
Net Margin %
1.09%
ROE %
0.62%
ROCE %
1.13%
0.44%
Debtor Days
163
Inventory Days
22
Payable Days
45
140
Debt to Equity (x)
0.20x
Interest Coverage (x)
5.50x
3.59x
Revenue Growth %
427.61%
Operating Profit Growth %
104.82%
Net Profit Growth %
-34.28%
-9.86%
P/E (x)
386.61x
P/B (x)
18.64x
Dividend Yield %
0.01%
1144.95x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
74.91
5.07
1.68
Government
0.00
18.33
Sep 2024
74.91
5.07
1.68
Government
0.00
18.33
Dec 2024
74.91
5.07
1.68
Government
0.00
18.33
Mar 2025
62.81
5.23
1.44
Government
0.00
30.51
Jun 2025
61.80
5.55
1.42
Government
0.00
31.23
Sep 2025
61.80
5.57
1.42
Government
0.00
31.21
Dec 2025
61.80
4.85
1.36
Government
0.00
31.99
Mar 2026
62.15
4.97
1.38
Government
0.00
31.50
Jun 2026
62.15
5.48
1.35
Government
0.00
31.02

Documents

Announcements

  • General Updates

    2026-08-17 - Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants

  • Resignation of Director/KMP/SMP

    2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP

Credit Ratings

Nothing filed yet.

Concalls